Literature DB >> 692577

The relation of product formulation to absorption of oral theophylline.

M Weinberger, L Hendeles, L Bighley.   

Abstract

To assess the potential for therapeutic problems related to the bioavailability of oral theophylline preparations, we examined the rate and extent of absorption for various formulations in adult volunteers. Absorption of theophylline from a solution or from uncoated tablets was rapid and complete. Three of six sustained-release formulations were more slowly, but still completely and consistently, absorbed. Absorption of the other three sustained-release formulations appeared to be more erratic and less complete. Serum concentration-time curves during multiple eight-hour dosing were simulated for the bioavailable preparations. With three sustained-release formulations it was predicted that fluctuations in serum theophylline concentrations between doses would decrease, as compared with uncoated tablets, to a clinically important extent, particularly in children, in whom elimination of theophylline is generally rapid.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692577     DOI: 10.1056/NEJM197810192991603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  42 in total

1.  Advocating for patients through clinical research.

Authors:  Leslie Hendeles
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

2.  The relationship between theophylline clearance and age in adult life.

Authors:  S H Jackson; A Johnston; R Woollard; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).

Authors:  Ryuichi Ogawa; Joan M Stachnik; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

4.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

Review 5.  New drugs in respiratory disorders: I.

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

Review 6.  Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.

Authors:  J G Wagner
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

Review 7.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Theophylline-controlled release preparations and fatty food: an in vitro study using the rotating dialysis cell method.

Authors:  S K el-Arini; G K Shiu; J P Skelly
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

10.  Pharmacokinetics of sustained release theophylline in low and high multidose regimens.

Authors:  G H Koëter; J H Jonkman; K de Vries; R Schoenmaker; J E Greving; R A de Zeeuw
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.